SME Times is powered by   
Search News
Just in:   • Sensex down 74 points, Nifty closes at 11,017  • TDF scheme to encourage MSMEs for defence manufacturing: Rajnath  • Banking reforms to be tailored to local needs: RBI official  • RERA a resounding success: Minister  • Despite extension, US sanctions politically motivated: Huawei 
Last updated: 05 Dec, 2018  

Novartis.9.Thmb.jpg Novartis India MD Milan Paleja to step down on May 31

Novartis.9.jpg
   Top Stories
» TDF scheme to encourage MSMEs for defence manufacturing: Rajnath
» Banking reforms to be tailored to local needs: RBI official
» RERA a resounding success: Minister
» National conference of tourism ministers concludes
» Corporate tax to be cut gradually: Sitharaman
SME Times News Bureau | 05 Dec, 2018
Pharmaceutical major Novartis India on Wednesday said its Vice Chairman and Managing Director Milan Paleja will step down from the post on May 31, 2019.

The company said in a regulatory filing to the BSE that Paleja has decided to relinquish current standing in the company "for embracing challenges outside of Novartis".

"The Board requested the Nomination and Remuneration Committee to identify and recommend a suitable successor for the role of Managing Director of the company," it said.

Shares of Novartis India on Wednesday settled at Rs 741.65 apiece on the BSE, higher Rs 51.10 or 7.40 per cent from the previous close.
 
Print the Page
Add to Favorite
 
Share this on :
 

Please comment on this story:
 
Subject :
Message:
(Maximum 1500 characters)  Characters left 1500
Your name:
 

 
  Customs Exchange Rates
Currency Import Export
US Dollar
66.20
64.50
UK Pound
87.50
84.65
Euro
78.25
75.65
Japanese Yen 58.85 56.85
As on 21 Aug, 2019
  Daily Poll
Is the Union Budget 2019 MSME-friendly?
 Yes
 No
 Can't say
  Commented Stories
» Sitharaman meets realty players, discuss liquidity(1)
» US military official visits Turkey for intervention in Syria(1)
» Indian SMEs lagging behind in technology adoption: Marg ERP MD(1)
 
 
About Us  |   Advertise with Us  
  Useful Links  |   Terms and Conditions  |   Disclaimer  |   Contact Us  
Follow Us : Facebook Twitter